UTHR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $478,561,944.83

United Therapeutics Insider Trading History Chart

United Therapeutics Share Price & Price History

^$478.27

▲ +3.27 (0.69%)

As of 02/3/2026 05:00 PM ET

Days: 30 | 90 | 365

United Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/3/2026	Jan Malcolm	Director	Sell	50	$474.23	$23,711.50	270
2/2/2026	Michael Benkowitz	COO	Sell	22,500	$470.95	$10,596,375.00
1/26/2026	Michael Benkowitz	COO	Sell	22,500	$471.91	$10,617,975.00
1/20/2026	Michael Benkowitz	COO	Sell	7,875	$464.66	$3,659,197.50
1/20/2026	Michael Benkowitz	COO	Sell	14,625	$464.66	$6,795,652.50
1/16/2026	Jan Malcolm	Director	Sell	50	$460.98	$23,049.00	320
1/15/2026	Paul A. Mahon	EVP	Sell	8,300	$469.89	$3,900,087.00	36,781
1/12/2026	Michael Benkowitz	COO	Sell	22,500	$479.51	$10,788,975.00
1/6/2026	Christopher Causey	Director	Sell	1,000	$510.00	$510,000.00	4,190
1/5/2026	Jan Malcolm	Director	Sell	50	$495.01	$24,750.50	370
1/5/2026	Michael Benkowitz	COO	Sell	14,625	$487.38	$7,127,932.50
1/5/2026	Michael Benkowitz	COO	Sell	7,875	$487.38	$3,838,117.50
1/2/2026	Christopher Causey	Director	Sell	1,000	$500.01	$500,010.00	4,190
1/2/2026	Paul A. Mahon	EVP	Sell	8,300	$485.43	$4,029,069.00	36,781
12/29/2025	Michael Benkowitz	COO	Sell	22,500	$502.79	$11,312,775.00
12/24/2025	Paul A. Mahon	EVP	Sell	11,000	$513.18	$5,644,980.00	36,781
12/23/2025	Jan Malcolm	Director	Sell	50	$512.12	$25,606.00	420
12/22/2025	Louis W. Sullivan	Director	Sell	5,950	$512.13	$3,047,173.50
12/22/2025	Michael Benkowitz	COO	Sell	22,500	$514.35	$11,572,875.00
12/19/2025	Martine A Rothblatt	CEO	Sell	2,000	$507.07	$1,014,140.00	130
12/18/2025	Tommy G. Thompson	Director	Sell	910	$500.59	$455,536.90	8,480
12/17/2025	Martine A Rothblatt	CEO	Sell	4,000	$501.04	$2,004,160.00	130
12/15/2025	Christopher Patusky	Director	Sell	1,000	$495.95	$495,950.00	1,490
12/15/2025	James Edgemond	CFO	Sell	3,517	$495.36	$1,742,181.12	8,142
12/15/2025	Martine A Rothblatt	CEO	Sell	4,000	$494.72	$1,978,880.00	130
12/15/2025	Michael Benkowitz	COO	Sell	22,500	$496.30	$11,166,750.00
12/12/2025	Martine A Rothblatt	CEO	Sell	4,000	$490.70	$1,962,800.00	130
12/11/2025	Jan Malcolm	Director	Sell	50	$482.98	$24,149.00	470
12/11/2025	Paul A. Mahon	EVP	Sell	11,000	$484.67	$5,331,370.00	36,781
12/10/2025	Martine A Rothblatt	CEO	Sell	4,000	$480.05	$1,920,200.00	130
12/9/2025	Nilda Mesa	Director	Sell	187	$481.63	$90,064.81	5,286
12/8/2025	James Edgemond	CFO	Sell	21,000	$478.60	$10,050,600.00	8,142
12/8/2025	Martine A Rothblatt	CEO	Sell	4,000	$484.23	$1,936,920.00	130
12/8/2025	Michael Benkowitz	COO	Sell	22,500	$478.58	$10,768,050.00
12/5/2025	Martine A Rothblatt	CEO	Sell	4,000	$483.28	$1,933,120.00	130
12/3/2025	Martine A Rothblatt	CEO	Sell	4,000	$475.27	$1,901,080.00	130
12/1/2025	James Edgemond	CFO	Sell	21,000	$479.99	$10,079,790.00	8,142
12/1/2025	Martine A Rothblatt	CEO	Sell	4,000	$481.93	$1,927,720.00	130
12/1/2025	Michael Benkowitz	COO	Sell	22,500	$479.91	$10,797,975.00
11/28/2025	Martine A Rothblatt	CEO	Sell	4,000	$487.64	$1,950,560.00	130
11/26/2025	Paul A. Mahon	EVP	Sell	11,000	$486.06	$5,346,660.00	36,781
11/25/2025	Martine A Rothblatt	CEO	Sell	4,000	$475.33	$1,901,320.00	130
11/24/2025	James Edgemond	CFO	Sell	21,000	$473.64	$9,946,440.00	8,142
11/24/2025	Michael Benkowitz	COO	Sell	22,500	$473.66	$10,657,350.00
11/21/2025	Martine A Rothblatt	CEO	Sell	4,000	$474.64	$1,898,560.00	130
11/19/2025	Martine A Rothblatt	CEO	Sell	4,000	$474.58	$1,898,320.00	130
11/17/2025	James Edgemond	CFO	Sell	21,000	$470.36	$9,877,560.00	8,118
11/17/2025	Martine A Rothblatt	CEO	Sell	4,000	$467.55	$1,870,200.00	130
11/17/2025	Michael Benkowitz	COO	Sell	22,500	$470.43	$10,584,675.00
11/14/2025	Martine A Rothblatt	CEO	Sell	4,000	$462.94	$1,851,760.00	130
11/13/2025	Paul A. Mahon	EVP	Sell	11,000	$464.76	$5,112,360.00	36,781
11/12/2025	Martine A Rothblatt	CEO	Sell	4,000	$460.00	$1,840,000.00	130
11/10/2025	James Edgemond	CFO	Sell	21,000	$452.07	$9,493,470.00	8,118
11/10/2025	Michael Benkowitz	COO	Sell	22,500	$452.07	$10,171,575.00
11/7/2025	Martine A Rothblatt	CEO	Sell	4,000	$448.25	$1,793,000.00	130
11/5/2025	Martine A Rothblatt	CEO	Sell	4,000	$437.98	$1,751,920.00	130
11/4/2025	James Edgemond	CFO	Sell	21,000	$436.09	$9,157,890.00	8,118
11/3/2025	Martine A Rothblatt	CEO	Sell	4,000	$438.30	$1,753,200.00	130
11/3/2025	Michael Benkowitz	COO	Sell	22,500	$429.25	$9,658,125.00
10/30/2025	Martine A Rothblatt	CEO	Sell	4,000	$448.96	$1,795,840.00	130
10/30/2025	Paul A. Mahon	EVP	Sell	11,000	$450.34	$4,953,740.00	36,781
10/27/2025	Martine A Rothblatt	CEO	Sell	4,000	$415.54	$1,662,160.00	130
10/27/2025	Michael Benkowitz	COO	Sell	22,500	$417.50	$9,393,750.00
10/24/2025	Martine A Rothblatt	CEO	Sell	4,000	$424.06	$1,696,240.00	130
10/22/2025	Martine A Rothblatt	CEO	Sell	4,000	$422.15	$1,688,600.00	130
10/20/2025	Martine A Rothblatt	CEO	Sell	4,000	$424.59	$1,698,360.00	130
10/20/2025	Michael Benkowitz	COO	Sell	22,500	$427.41	$9,616,725.00
10/16/2025	Martine A Rothblatt	CEO	Sell	4,000	$431.31	$1,725,240.00	130
10/16/2025	Paul A. Mahon	EVP	Sell	11,000	$431.50	$4,746,500.00	36,781
10/13/2025	Martine A Rothblatt	CEO	Sell	4,000	$440.43	$1,761,720.00	130
10/13/2025	Michael Benkowitz	COO	Sell	22,500	$440.35	$9,907,875.00
10/10/2025	Martine A Rothblatt	CEO	Sell	4,000	$444.70	$1,778,800.00	130
10/8/2025	Martine A Rothblatt	CEO	Sell	4,000	$450.86	$1,803,440.00	130
10/6/2025	Martine A Rothblatt	CEO	Sell	4,000	$449.69	$1,798,760.00	130
10/6/2025	Michael Benkowitz	COO	Sell	22,500	$450.24	$10,130,400.00
10/2/2025	Martine A Rothblatt	CEO	Sell	4,000	$434.88	$1,739,520.00	130
10/2/2025	Paul A. Mahon	EVP	Sell	11,000	$436.60	$4,802,600.00	36,781
9/29/2025	Martine A Rothblatt	CEO	Sell	4,000	$425.63	$1,702,520.00	130
9/29/2025	Michael Benkowitz	COO	Sell	22,500	$421.80	$9,490,500.00
9/26/2025	Martine A Rothblatt	CEO	Sell	4,000	$428.22	$1,712,880.00	130
9/24/2025	Christopher Causey	Director	Sell	1,000	$440.00	$440,000.00	4,865
9/24/2025	Martine A Rothblatt	CEO	Sell	4,000	$434.12	$1,736,480.00	130
9/22/2025	Martine A Rothblatt	CEO	Sell	4,000	$417.30	$1,669,200.00	130
9/22/2025	Michael Benkowitz	COO	Sell	22,500	$416.35	$9,367,875.00
9/19/2025	Judy D. Olian	Director	Sell	1,800	$415.43	$747,774.00	5,045
9/19/2025	Martine A Rothblatt	CEO	Sell	4,000	$411.08	$1,644,320.00	130
9/18/2025	Paul A. Mahon	EVP	Sell	11,000	$406.17	$4,467,870.00	36,781
9/17/2025	Martine A Rothblatt	CEO	Sell	4,000	$400.17	$1,600,680.00	130
9/15/2025	Martine A Rothblatt	CEO	Sell	4,000	$397.88	$1,591,520.00	130
9/15/2025	Michael Benkowitz	COO	Sell	22,500	$400.56	$9,012,600.00
9/11/2025	Martine A Rothblatt	CEO	Sell	4,000	$397.23	$1,588,920.00	130
9/10/2025	Tommy G. Thompson	Director	Sell	4,560	$403.36	$1,839,321.60	8,480
9/9/2025	Jan Malcolm	Director	Sell	700	$400.29	$280,203.00	520
9/9/2025	Martine A Rothblatt	CEO	Sell	8,000	$398.55	$3,188,400.00	130
9/9/2025	Michael Benkowitz	COO	Sell	11,375	$397.41	$4,520,538.75
9/8/2025	Michael Benkowitz	COO	Sell	5,000	$392.21	$1,961,050.00
9/4/2025	Paul A. Mahon	EVP	Sell	11,000	$385.21	$4,237,310.00	36,781
9/2/2025	Christopher Causey	Director	Sell	3,000	$423.21	$1,269,630.00	4,865
9/2/2025	Michael Benkowitz	COO	Sell	22,500	$417.64	$9,396,900.00
8/21/2025	Paul A. Mahon	EVP	Sell	11,000	$308.75	$3,396,250.00	36,781
8/7/2025	Paul A. Mahon	EVP	Sell	11,000	$300.00	$3,300,000.00	36,781
7/24/2025	Paul A. Mahon	EVP	Sell	11,000	$304.11	$3,345,210.00	36,781
7/10/2025	Paul A. Mahon	EVP	Sell	11,000	$300.31	$3,303,410.00	36,781
6/26/2025	Paul A. Mahon	EVP	Sell	11,000	$285.70	$3,142,700.00	36,781
6/24/2025	Nilda Mesa	Director	Sell	645	$289.99	$187,043.55	4,883
6/24/2025	Richard Giltner	Director	Sell	3,036	$289.60	$879,225.60	19,384
6/12/2025	Paul A. Mahon	EVP	Sell	11,000	$279.96	$3,079,560.00	36,781
6/9/2025	James Edgemond	CFO	Sell	12,000	$325.37	$3,904,440.00	8,118
5/29/2025	Paul A. Mahon	EVP	Sell	11,000	$316.07	$3,476,770.00	36,781
5/1/2025	Paul A. Mahon	EVP	Sell	11,000	$300.93	$3,310,230.00	36,781
4/21/2025	Raymond A. Dwek	Director	Sell	3,000	$285.57	$856,710.00	1,750
4/17/2025	Paul A. Mahon	EVP	Sell	11,000	$283.78	$3,121,580.00	36,781
4/14/2025	Raymond A. Dwek	Director	Sell	3,000	$285.16	$855,480.00	1,750
4/7/2025	Raymond A. Dwek	Director	Sell	4,000	$284.55	$1,138,200.00	1,750
4/3/2025	Paul A. Mahon	EVP	Sell	11,000	$306.18	$3,367,980.00	36,781
3/24/2025	Tommy G. Thompson	Director	Sell	2,500	$318.80	$797,000.00	8,480
2/24/2025	Michael Benkowitz	COO	Sell	10,000	$360.76	$3,607,600.00	2,577
2/18/2025	Michael Benkowitz	COO	Sell	10,000	$371.05	$3,710,500.00	2,577
2/10/2025	Michael Benkowitz	COO	Sell	10,000	$348.06	$3,480,600.00	2,577
2/3/2025	Michael Benkowitz	COO	Sell	10,000	$353.64	$3,536,400.00	2,577
1/27/2025	Michael Benkowitz	COO	Sell	10,000	$370.71	$3,707,100.00	2,577
1/21/2025	Michael Benkowitz	COO	Sell	10,000	$364.91	$3,649,100.00	2,577
1/13/2025	Michael Benkowitz	COO	Sell	10,000	$364.62	$3,646,200.00	2,577
12/30/2024	Michael Benkowitz	COO	Sell	10,000	$356.68	$3,566,800.00	2,577
12/30/2024	Nilda Mesa	Director	Sell	255	$355.77	$90,721.35	5,528
12/23/2024	Michael Benkowitz	COO	Sell	10,000	$361.95	$3,619,500.00	2,577
12/18/2024	Louis W. Sullivan	Director	Sell	26,209	$373.22	$9,781,722.98	5,051
12/5/2024	Paul A. Mahon	EVP	Sell	7,700	$374.37	$2,882,649.00	36,710
11/25/2024	Michael Benkowitz	COO	Sell	10,000	$372.75	$3,727,500.00	2,577
11/21/2024	Paul A. Mahon	EVP	Sell	7,700	$367.36	$2,828,672.00	36,710
11/11/2024	Judy D. Olian	Director	Sell	1,750	$412.48	$721,840.00	5,655
11/11/2024	Michael Benkowitz	COO	Sell	15,000	$407.32	$6,109,800.00
11/8/2024	Nilda Mesa	Director	Sell	224	$412.28	$92,350.72	5,783
11/7/2024	Michael Benkowitz	COO	Sell	15,000	$401.44	$6,021,600.00	2,577
11/1/2024	Christopher Causey	Director	Sell	510	$376.63	$192,081.30	3,675
11/1/2024	Michael Benkowitz	COO	Sell	14,700	$374.46	$5,504,562.00	2,577
10/28/2024	James Edgemond	CFO	Sell	7,800	$350.00	$2,730,000.00	6,978
10/21/2024	James Edgemond	CFO	Sell	7,782	$366.99	$2,855,916.18	6,426
10/14/2024	James Edgemond	CFO	Sell	7,792	$355.88	$2,773,016.96	5,884
10/7/2024	James Edgemond	CFO	Sell	7,794	$355.54	$2,771,078.76	5,344
9/30/2024	James Edgemond	CFO	Sell	7,792	$358.62	$2,794,367.04	4,802
9/23/2024	James Edgemond	CFO	Sell	7,796	$354.04	$2,760,095.84	4,264
9/9/2024	James Edgemond	CFO	Sell	7,802	$345.41	$2,694,888.82	3,210
9/3/2024	James Edgemond	CFO	Sell	7,785	$362.37	$2,821,050.45	2,615
8/26/2024	Martine A Rothblatt	CEO	Sell	269	$348.41	$93,722.29	130
8/19/2024	Martine A Rothblatt	CEO	Sell	3,600	$344.18	$1,239,048.00	130
8/8/2024	Martine A Rothblatt	CEO	Sell	3,600	$328.39	$1,182,204.00	130
8/7/2024	Michael Benkowitz	COO	Sell	25,000	$323.38	$8,084,500.00	2,577
8/6/2024	Martine A Rothblatt	CEO	Sell	3,600	$325.45	$1,171,620.00	130
8/2/2024	Martine A Rothblatt	CEO	Sell	3,600	$324.73	$1,169,028.00	130
8/2/2024	Raymond A. Dwek	Director	Sell	5,000	$325.35	$1,626,750.00	1,750
7/30/2024	Martine A Rothblatt	CEO	Sell	3,600	$337.40	$1,214,640.00	130
7/26/2024	Martine A Rothblatt	CEO	Sell	3,600	$338.61	$1,218,996.00	130
7/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$334.00	$1,202,400.00	130
7/22/2024	Martine A Rothblatt	CEO	Sell	3,600	$331.32	$1,192,752.00	130
7/18/2024	Martine A Rothblatt	CEO	Sell	3,600	$331.79	$1,194,444.00	130
7/16/2024	Martine A Rothblatt	CEO	Sell	3,600	$328.03	$1,180,908.00	130
7/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$324.97	$1,169,892.00	130
7/10/2024	Martine A Rothblatt	CEO	Sell	3,600	$326.35	$1,174,860.00	130
7/8/2024	Martine A Rothblatt	CEO	Sell	3,600	$317.05	$1,141,380.00	130
7/5/2024	Martine A Rothblatt	CEO	Sell	3,600	$313.25	$1,127,700.00	130
7/3/2024	Martine A Rothblatt	CEO	Sell	3,600	$312.48	$1,124,928.00	130
7/1/2024	Martine A Rothblatt	CEO	Sell	3,600	$320.45	$1,153,620.00	130
6/27/2024	Martine A Rothblatt	CEO	Sell	3,600	$316.62	$1,139,832.00	130
6/25/2024	Nilda Mesa	Director	Sell	266	$318.58	$84,742.28	5,107
6/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$315.97	$1,137,492.00	130
6/21/2024	Martine A Rothblatt	CEO	Sell	3,600	$313.91	$1,130,076.00	130
6/14/2024	Martine A Rothblatt	CEO	Sell	3,600	$287.22	$1,033,992.00	130
6/13/2024	Christopher Causey	Director	Sell	2,000	$281.53	$563,060.00	4,185
6/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$281.19	$1,012,284.00	130
6/10/2024	Martine A Rothblatt	CEO	Sell	3,600	$273.95	$986,220.00	130
6/7/2024	Martine A Rothblatt	CEO	Sell	3,600	$277.13	$997,668.00	130
5/31/2024	Martine A Rothblatt	CEO	Sell	3,600	$272.48	$980,928.00	130
5/28/2024	Martine A Rothblatt	Director	Sell	3,600	$269.06	$968,616.00	130
5/23/2024	Martine A Rothblatt	Director	Sell	3,600	$275.78	$992,808.00	130
5/21/2024	Martine A Rothblatt	Director	Sell	1,468	$275.85	$404,947.80	130
5/16/2024	Martine A Rothblatt	Director	Sell	3,600	$272.37	$980,532.00	130
5/14/2024	Christopher Patusky	Director	Sell	1,310	$264.35	$346,298.50
5/13/2024	Martine A Rothblatt	CEO	Sell	3,600	$265.48	$955,728.00	130
5/9/2024	Martine A Rothblatt	CEO	Sell	3,600	$264.22	$951,192.00	130
5/6/2024	Martine A Rothblatt	CEO	Sell	3,600	$259.70	$934,920.00	130
5/3/2024	Christopher Causey	Director	Sell	2,240	$259.91	$582,198.40	4,185
5/2/2024	Martine A Rothblatt	CEO	Sell	3,600	$258.09	$929,124.00	130
4/30/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.35	$847,260.00	130
4/26/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.20	$846,720.00	130
4/24/2024	Martine A Rothblatt	CEO	Sell	3,600	$238.81	$859,716.00	130
4/22/2024	Martine A Rothblatt	CEO	Sell	3,600	$236.47	$851,292.00	130
4/18/2024	Martine A Rothblatt	CEO	Sell	3,600	$237.91	$856,476.00	130
4/16/2024	Martine A Rothblatt	CEO	Sell	3,600	$232.05	$835,380.00	130
4/12/2024	Martine A Rothblatt	CEO	Sell	3,600	$235.42	$847,512.00	130
4/10/2024	Martine A Rothblatt	CEO	Sell	13,800	$237.27	$3,274,326.00	130
4/8/2024	Martine A Rothblatt	CEO	Sell	5,060	$237.52	$1,201,851.20	130
4/4/2024	Martine A Rothblatt	CEO	Sell	15,000	$233.27	$3,499,050.00	130
4/4/2024	Paul A. Mahon	EVP	Sell	6,000	$232.37	$1,394,220.00	36,710
3/28/2024	Martine A Rothblatt	CEO	Sell	14,125	$236.18	$3,336,042.50	130
3/27/2024	Nilda Mesa	Director	Sell	325	$237.80	$77,285.00	5,373
3/26/2024	Martine A Rothblatt	CEO	Sell	15,000	$248.33	$3,724,950.00	130
3/22/2024	Martine A Rothblatt	CEO	Sell	15,000	$237.05	$3,555,750.00	130
3/21/2024	Paul A. Mahon	EVP	Sell	6,000	$236.45	$1,418,700.00	36,710
3/19/2024	Martine A Rothblatt	CEO	Sell	15,000	$236.59	$3,548,850.00	130
2/23/2024	Christopher Patusky	Director	Sell	1,680	$224.00	$376,320.00	4
2/15/2024	Paul A. Mahon	EVP	Sell	6,000	$215.31	$1,291,860.00	36,599
2/1/2024	Paul A. Mahon	EVP	Sell	6,000	$215.01	$1,290,060.00	36,599
1/18/2024	Paul A. Mahon	EVP	Sell	6,000	$218.72	$1,312,320.00	36,599
1/4/2024	Paul A. Mahon	EVP	Sell	6,000	$227.97	$1,367,820.00	36,599
12/21/2023	Paul A. Mahon	EVP	Sell	6,000	$229.27	$1,375,620.00	36,599
12/19/2023	Nilda Mesa	Director	Sell	605	$244.90	$148,164.50	5,698
12/12/2023	Christopher Causey	Director	Sell	3,000	$249.68	$749,040.00	4,585
12/7/2023	Paul A. Mahon	EVP	Sell	6,000	$238.89	$1,433,340.00	36,599
11/2/2023	Paul A. Mahon	EVP	Sell	6,000	$225.76	$1,354,560.00	36,599
10/19/2023	Paul A. Mahon	EVP	Sell	6,000	$225.43	$1,352,580.00	36,599
10/5/2023	Paul A. Mahon	EVP	Sell	6,000	$223.82	$1,342,920.00	36,599
9/21/2023	Paul A. Mahon	EVP	Sell	6,000	$222.19	$1,333,140.00	36,599
9/13/2023	Nilda Mesa	Director	Sell	383	$222.36	$85,163.88	6,303
9/7/2023	Paul A. Mahon	EVP	Sell	6,000	$222.98	$1,337,880.00	36,599
8/3/2023	Paul A. Mahon	EVP	Sell	6,000	$236.25	$1,417,500.00	36,599
7/20/2023	Paul A. Mahon	EVP	Sell	2,500	$243.87	$609,675.00	36,599
7/6/2023	Paul A. Mahon	EVP	Sell	6,000	$215.19	$1,291,140.00	36,599
6/15/2023	Paul A. Mahon	EVP	Sell	6,000	$227.77	$1,366,620.00	36,599
6/1/2023	Paul A. Mahon	EVP	Sell	6,000	$209.11	$1,254,660.00	36,599
5/18/2023	Paul A. Mahon	EVP	Sell	6,000	$214.58	$1,287,480.00	36,599
5/5/2023	Nilda Mesa	Director	Sell	374	$214.81	$80,338.94	5,806
5/4/2023	Paul A. Mahon	EVP	Sell	6,000	$215.82	$1,294,920.00	36,599
5/1/2023	Martine A Rothblatt	CEO	Sell	8,000	$231.40	$1,851,200.00	130
4/28/2023	Martine A Rothblatt	CEO	Sell	8,000	$229.32	$1,834,560.00	130
4/26/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.01	$1,808,080.00	130
4/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$228.64	$1,829,120.00	130
4/21/2023	Martine A Rothblatt	CEO	Sell	8,000	$228.82	$1,830,560.00	130
4/20/2023	Christopher Patusky	Director	Buy	6	$114.06	$684.36	1,686
4/20/2023	Paul A. Mahon	EVP	Sell	6,000	$223.96	$1,343,760.00	36,599
4/19/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.12	$1,808,960.00	130
4/17/2023	Martine A Rothblatt	CEO	Sell	8,000	$230.47	$1,843,760.00	130
4/13/2023	Martine A Rothblatt	CEO	Sell	8,000	$230.69	$1,845,520.00	130
4/11/2023	Martine A Rothblatt	CEO	Sell	8,000	$225.57	$1,804,560.00	130
4/6/2023	Martine A Rothblatt	CEO	Sell	8,000	$229.12	$1,832,960.00	130
4/6/2023	Paul A. Mahon	EVP	Sell	6,000	$232.79	$1,396,740.00	36,599
4/4/2023	Martine A Rothblatt	CEO	Sell	8,000	$226.26	$1,810,080.00	130
3/30/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.14	$1,737,120.00	130
3/27/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.04	$1,736,320.00	130
3/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.95	$1,743,600.00	130
3/22/2023	Martine A Rothblatt	CEO	Sell	8,000	$216.01	$1,728,080.00	130
3/20/2023	Christopher Patusky	Director	Sell	5	$107.71	$538.55	1,680
3/20/2023	Martine A Rothblatt	CEO	Sell	8,000	$223.96	$1,791,680.00	130
3/17/2023	Martine A Rothblatt	CEO	Sell	8,000	$217.91	$1,743,280.00	130
3/16/2023	Paul A. Mahon	EVP	Sell	6,000	$214.39	$1,286,340.00	36,599
3/9/2023	Martine A Rothblatt	CEO	Sell	8,000	$222.63	$1,781,040.00	130
3/7/2023	Martine A Rothblatt	CEO	Sell	8,000	$239.16	$1,913,280.00	121
3/2/2023	Martine A Rothblatt	CEO	Sell	8,000	$244.50	$1,956,000.00	130
2/27/2023	Martine A Rothblatt	CEO	Sell	8,000	$249.14	$1,993,120.00	130
2/24/2023	Martine A Rothblatt	CEO	Sell	8,000	$249.27	$1,994,160.00	130
2/22/2023	Martine A Rothblatt	CEO	Sell	8,000	$246.77	$1,974,160.00	130
2/13/2023	Martine A Rothblatt	CEO	Sell	8,000	$254.76	$2,038,080.00	130
2/8/2023	Martine A Rothblatt	CEO	Sell	8,000	$253.38	$2,027,040.00	130

SEC Filings (Institutional Ownership Changes) for United Therapeutics (NASDAQ:UTHR)

94.08% of United Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

United Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2026	Stiles Financial Services Inc	458	$0.22M	0.1%	N/A	0.001%
2/3/2026	Denali Advisors LLC	1,702	$0.83M	0.1%	-10.6%	0.004%
2/3/2026	Drucker Wealth 3.0 LLC	666	$0.33M	0.1%	+20.7%	0.002%
2/3/2026	Legacy Wealth Managment LLC ID	100	$49K	0.0%	+284.6%	0.000%
2/3/2026	F m Investments LLC	7,600	$3.70M	0.1%	+38.8%	0.018%
2/3/2026	Crossmark Global Holdings Inc.	3,281	$1.60M	0.0%	-6.2%	0.008%
2/3/2026	Ethic Inc.	956	$0.47M	0.0%	+9.5%	0.002%
2/3/2026	Ballentine Partners LLC	549	$0.27M	0.0%	+10.2%	0.001%
2/3/2026	Virtus Family Office LLC	3,708	$1.81M	1.6%	-1.1%	0.009%
2/3/2026	Generali Asset Management SPA SGR	2,974	$1.45M	0.0%	-35.7%	0.007%
2/3/2026	Allegiance Financial Group Advisory Services LLC	554	$0.27M	0.1%	N/A	0.001%
2/3/2026	Sequoia Financial Advisors LLC	3,271	$1.59M	0.0%	+83.4%	0.008%
2/3/2026	Swedbank AB	324,772	$158.25M	0.2%	-1.3%	0.754%
2/3/2026	Mitsubishi UFJ Asset Management Co. Ltd.	40,902	$20.32M	0.0%	-0.1%	0.095%
2/3/2026	BOKF NA	7,147	$3.48M	0.1%	-8.0%	0.017%
2/3/2026	Sumitomo Mitsui DS Asset Management Company Ltd	5,062	$2.47M	0.0%	+29.3%	0.012%
2/3/2026	SBI Securities Co. Ltd.	424	$0.21M	0.0%	-7.2%	0.001%
2/2/2026	Principal Financial Group Inc.	98,158	$47.83M	0.0%	-7.2%	0.228%
2/2/2026	QRG Capital Management Inc.	4,690	$2.29M	0.0%	+14.4%	0.011%
2/2/2026	Seizert Capital Partners LLC	145,522	$70.91M	3.0%	-1.0%	0.338%
2/2/2026	PKO Investment Management Joint Stock Co	500	$0.24M	0.0%	N/A	0.001%
2/2/2026	Strs Ohio	16,416	$8M	0.0%	+63.1%	0.038%
2/2/2026	Composition Wealth LLC	579	$0.28M	0.0%	N/A	0.001%
2/2/2026	Horizon Investments LLC	27,382	$13.34M	0.2%	+28.3%	0.064%
2/2/2026	Danske Bank A S	19,473	$9.49M	0.0%	+21.8%	0.045%
2/2/2026	GenTrust LLC	453	$0.22M	0.0%	N/A	0.001%
2/2/2026	Oppenheimer & Co. Inc.	3,196	$1.56M	0.0%	-25.6%	0.007%
2/2/2026	Oppenheimer Asset Management Inc.	18,383	$8.96M	0.1%	-0.7%	0.043%
1/30/2026	Citizens Financial Group Inc. RI	428	$0.21M	0.0%	N/A	0.001%
1/30/2026	New York State Teachers Retirement System	50,872	$24.79M	0.0%	-7.2%	0.118%
1/30/2026	Activest Wealth Management	60	$29K	0.0%	+1,400.0%	0.000%
1/30/2026	State of New Jersey Common Pension Fund D	14,496	$7.06M	0.0%	-4.3%	0.034%
1/30/2026	Sage Rhino Capital LLC	451	$0.22M	0.0%	N/A	0.001%
1/30/2026	Archer Investment Corp	419	$0.20M	0.0%	+17.7%	0.001%
1/30/2026	Cadence Bank	4,049	$1.97M	0.1%	+3.6%	0.009%
1/30/2026	Torren Management LLC	53	$26K	0.0%	N/A	0.000%
1/30/2026	Mitsubishi UFJ Trust & Banking Corp	27,786	$13.54M	0.0%	-48.6%	0.065%
1/30/2026	M&T Bank Corp	3,142	$1.53M	0.0%	+171.6%	0.007%
1/29/2026	Comerica Bank	161,683	$78.78M	0.3%	+2.4%	0.375%
1/29/2026	Ashton Thomas Private Wealth LLC	1,954	$0.95M	0.0%	-2.9%	0.005%
1/29/2026	Anchyra Partners LLC	1,947	$0.95M	0.3%	N/A	0.005%
1/29/2026	Kestra Private Wealth Services LLC	2,355	$1.15M	0.0%	+133.6%	0.005%
1/29/2026	Pictet Asset Management Holding SA	306,837	$149.67M	0.1%	-4.6%	0.713%
1/29/2026	James Investment Research Inc.	3,391	$1.65M	0.2%	+42.7%	0.008%
1/29/2026	State of Michigan Retirement System	11,532	$5.62M	0.0%	-6.5%	0.027%
1/29/2026	ST Germain D J Co. Inc.	387	$0.19M	0.0%	N/A	0.001%
1/29/2026	UBS Group AG	225,849	$110.05M	0.0%	+45.3%	0.524%
1/29/2026	Sanctuary Advisors LLC	2,278	$1.11M	0.0%	+64.5%	0.005%
1/29/2026	Quent Capital LLC	4,292	$2.09M	0.2%	+342.9%	0.010%
1/29/2026	Teachers Retirement System of The State of Kentucky	30,864	$15.04M	0.1%	+120.6%	0.072%
1/29/2026	Vanguard Group Inc.	4,176,016	$2.03B	0.0%	-5.5%	9.698%
1/29/2026	Polaris Capital Management LLC	103,650	$50.50M	4.2%	-15.1%	0.241%
1/29/2026	Concurrent Investment Advisors LLC	2,275	$1.11M	0.0%	+137.7%	0.005%
1/29/2026	Compass Ion Advisors LLC	2,455	$1.20M	0.1%	-1.0%	0.006%
1/29/2026	China Universal Asset Management Co. Ltd.	7,516	$3.66M	0.3%	-24.3%	0.017%
1/28/2026	Arizona State Retirement System	11,759	$5.73M	0.0%	-6.3%	0.027%
1/28/2026	WPG Advisers LLC	109	$53K	0.0%	-54.0%	0.000%
1/28/2026	Atwood & Palmer Inc.	63,532	$30.96M	1.8%	-0.5%	0.148%
1/28/2026	Chicago Partners Investment Group LLC	1,006	$0.47M	0.0%	N/A	0.002%
1/28/2026	Quent Long Short Global Small Cap Fund LP	992	$0.48M	0.0%	N/A	0.002%
1/28/2026	waypoint wealth counsel	701	$0.34M	0.1%	N/A	0.002%
1/28/2026	Teacher Retirement System of Texas	6,748	$3.29M	0.0%	-38.9%	0.016%
1/28/2026	Trail Ridge Investment Advisors LLC	2,482	$1.21M	0.5%	+10.0%	0.006%
1/28/2026	HB Wealth Management LLC	2,006	$0.98M	0.0%	+35.8%	0.005%
1/28/2026	Kingswood Wealth Advisors LLC	564	$0.28M	0.0%	-6.2%	0.001%
1/28/2026	M&T Bank Corp	45,290	$22.07M	0.1%	+3,814.4%	0.105%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	19,418	$9.48M	0.0%	-50.3%	0.045%
1/27/2026	Meritage Portfolio Management	769	$0.38M	0.0%	-18.3%	0.002%
1/27/2026	Novem Group	2,230	$1.09M	0.1%	N/A	0.005%
1/27/2026	Evergreen Capital Management LLC	13,588	$6.62M	0.1%	+4.9%	0.032%
1/27/2026	TD Waterhouse Canada Inc.	1,220	$0.59M	0.0%	-11.7%	0.003%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	52,012	$25.34M	0.1%	+169.2%	0.121%
1/27/2026	Krilogy Financial LLC	1,753	$0.83M	0.0%	+68.4%	0.004%
1/27/2026	Earned Wealth Advisors LLC	564	$0.28M	0.0%	N/A	0.001%
1/27/2026	Seeds Investor LLC	1,476	$0.72M	0.1%	+9.7%	0.003%
1/27/2026	Tributary Capital Management LLC	760	$0.37M	0.0%	-30.0%	0.002%
1/27/2026	Lecap Asset Management Ltd.	696	$0.34M	0.1%	N/A	0.002%
1/27/2026	Asset Management One Co. Ltd.	23,267	$11.70M	0.0%	-5.1%	0.054%
1/27/2026	GF Fund Management CO. LTD.	845	$0.41M	0.0%	-13.2%	0.002%
1/26/2026	Merit Financial Group LLC	10,737	$5.23M	0.0%	+44.8%	0.025%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	4,302	$2.10M	0.0%	-8.5%	0.010%
1/26/2026	MBM Wealth Consultants LLC	2,035	$0.99M	0.2%	-2.5%	0.005%
1/26/2026	Parcion Private Wealth LLC	974	$0.48M	0.0%	N/A	0.002%
1/26/2026	Greenwood Capital Associates LLC	1,185	$0.58M	0.1%	-14.6%	0.003%
1/26/2026	Nations Financial Group Inc. IA ADV	4,044	$1.97M	0.1%	+14.9%	0.009%
1/26/2026	CWM LLC	23,909	$11.65M	0.0%	+160.2%	0.056%
1/26/2026	Childress Capital Advisors LLC	580	$0.28M	0.0%	N/A	0.001%
1/26/2026	KBC Group NV	23,370	$11.39M	0.0%	+43.2%	0.054%
1/26/2026	LBP AM SA	20,000	$9.75M	0.1%	N/A	0.046%
1/26/2026	MOKAN Wealth Management Inc.	548	$0.27M	0.1%	N/A	0.001%
1/23/2026	Farther Finance Advisors LLC	897	$0.44M	0.0%	+406.8%	0.002%
1/23/2026	Assetmark Inc.	634,956	$309.38M	0.6%	-1.7%	1.475%
1/23/2026	Meridian Financial Advisors LLC	690	$0.34M	0.2%	-11.5%	0.002%
1/23/2026	Transcend Capital Advisors LLC	641	$0.31M	0.0%	N/A	0.001%
1/23/2026	State of Alaska Department of Revenue	13,732	$6.69M	0.1%	-4.7%	0.032%
1/23/2026	Retirement Guys Formula LLC	498	$0.24M	0.1%	-18.4%	0.001%
1/23/2026	Baillie Gifford & Co.	323,016	$157.39M	0.1%	N/A	0.750%
1/23/2026	Burney Co.	10,801	$5.26M	0.2%	-3.9%	0.025%
1/23/2026	Sumitomo Mitsui Trust Group Inc.	92,156	$44.90M	0.0%	-2.7%	0.214%
1/23/2026	Robeco Institutional Asset Management B.V.	113,850	$55.47M	0.1%	+25.0%	0.264%

Data available starting January 2016

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Today's Range

Now: $478.27

$470.83

$480.86

50 Day Range

MA: $487.07

$464.93

$517.13

52 Week Range

Now: $478.27

$266.98

$519.99

Volume

281,607 shs

Average Volume

313,914 shs

Market Capitalization

$20.59 billion

P/E Ratio

18.12

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of United Therapeutics?: United Therapeutics' top insider shareholders include:
Paul A Mahon (EVP)
Richard Giltner (Director)
Tommy G Thompson (Director)
James Edgemond (CFO)
Nilda Mesa (Director)
Judy D Olian (Director)
Louis W Sullivan (Director)
Christopher Causey (Director)
Michael Benkowitz (COO)
Raymond Dwek (Director)
Christopher Patusky (Director)
Jan Malcolm (Director)
Martine A Rothblatt (CEO)
Martine A Rothblatt (Director)
Learn More about top insider investors at United Therapeutics.
Who are the major institutional investors of United Therapeutics?: United Therapeutics' top institutional investors include:
Vanguard Group Inc. — 9.70%
Assetmark Inc. — 1.47%
Swedbank AB — 0.75%
Baillie Gifford & Co. — 0.75%
Pictet Asset Management Holding SA — 0.71%
UBS Group AG — 0.52%
Learn More about top institutional investors of United Therapeutics stock.
Which major investors are selling United Therapeutics stock?: In the last quarter, UTHR stock was sold by these institutional investors:
Vanguard Group Inc.
Mitsubishi UFJ Trust & Banking Corp
Universal Beteiligungs und Servicegesellschaft mbH
Polaris Capital Management LLC
Pictet Asset Management Holding SA
Assetmark Inc.
Principal Financial Group Inc.
Wedge Capital Management L L P NC
In the last year, company insiders that have sold United Therapeutics company stock include:
Paul A Mahon (EVP)
Richard Giltner (Director)
Tommy G Thompson (Director)
James Edgemond (CFO)
Nilda Mesa (Director)
Judy D Olian (Director)
Louis W Sullivan (Director)
Christopher Causey (Director)
Michael Benkowitz (COO)
Raymond Dwek (Director)
Christopher Patusky (Director)
Jan Malcolm (Director)
Martine A Rothblatt (CEO)
Learn More investors selling United Therapeutics stock.
Which major investors are buying United Therapeutics stock?: Within the last quarter, UTHR stock was purchased by institutional investors including:
Baillie Gifford & Co.
UBS Group AG
IMC Chicago LLC
M&T Bank Corp
Zurcher Kantonalbank Zurich Cantonalbank
Robeco Institutional Asset Management B.V.
LBP AM SA
Teachers Retirement System of The State of Kentucky